The Hot Shower
The evidence

Is it even real?

Short answer: yes, and you're right to ask for proof. Here's the whole case, including the parts that are still uncertain. Read it and decide for yourself.

01The fact that ends the argument

American medicine gave it a code.

You don't have to take a stranger's word for it. On October 1, 2025, the US diagnostic-coding system added a specific code for CHS. It has an official number that a hospital anywhere in the country can bill under, today.

ICD-10-CM diagnostic code, effective October 1, 2025
R11.16
"Cannabis hyperemesis syndrome"
Added by the CDC's National Center for Health Statistics after 20 years in the medical literature.[5]
Codes don't get invented for hoaxes.

A condition earns one after enough hospitals, enough billing, and enough peer-reviewed papers force the system to name it. The first medical description came in 2004.[1] It took twenty years and a wave of ER visits to get here.

02What changed

The plant is not the plant your grandparents knew.

If CHS is new, something must have changed. It did. The single biggest change is potency. Average THC in cannabis has climbed roughly tenfold in two generations, from about one percent in the 1970s to twenty percent and up for today's flower.[8][9][10]

Average THC in cannabis, 1978 to 2022
Percent THC in tested samples. Each point is a published measurement.
0% 5% 10% 15% 20% 1978 1995 2014 2022 1.4% 3.9% 12% ~21%
Sources: US Potency Monitoring Program / DEA-seized samples, ElSohly et al.[8]; global meta-analysis, Freeman et al. 2021[9]; legal-dispensary product testing, Cash et al. 2020[10].

And that's just flower. The bigger break came with concentrates, the dabs, waxes, and vape distillates that went mainstream in the 2010s. Those run sixty to ninety percent THC, a potency with no natural analog anywhere in the plant's history.

Flower vs. concentrate, THC by weight
The product that arrived in the legal era is a different order of magnitude.
Today's flower (average)~21%
Concentrates / dabs / distillate60-90%
Scale of bars is percent THC by weight. Concentrate figures from DEA and industry product data.

At the same time, CBD, the part of the plant that buffers THC's effects, was bred out as a worthless trait. In 1995 the ratio of THC to CBD sat around 14 to 1. By 2014 it was roughly 80 to 1, and today CBD is often undetectable.[8]

1995
14 : 1
THC to CBD
2014
80 : 1
THC to CBD

And it isn't only how strong the product is, it's the form. In the largest patient survey, people who used concentrates and vapes developed CHS years faster than people who smoked flower, often in under a year, because a dab or a cart spikes blood-THC far higher in a single hit than flower ever could.[26]

03The GMO question

No, it isn't GMO. It's something breeders did.

A lot of people reach for "they must be genetically modifying it." That instinct is pointing at something true, but the word is wrong, and it's worth being precise, because being precise is what makes the rest of this page trustworthy.

The honest version

There is no genetically modified cannabis for sale, anywhere. No transgenic strains, no CRISPR flower on dispensary shelves. What actually happened is selective breeding, the same kind of thing that turned wild mustard into broccoli and cauliflower, plus sinsemilla growing, feminized seeds, and solvent extraction. Real gene-editing cannabis science exists, but it lives in yeast vats and university labs, not the stuff people smoke.[14][15]

So if you've said "that's not GMO," you're right. But here's the part that matters: your deeper instinct, that we've pushed this plant far past anything nature or history ever made, is dead on. Bred for maximum THC, stripped of CBD, extracted to ninety percent, and used all day long. Not genetically modified. Genuinely re-engineered.

04Is it new?

Humans used cannabis for 3,000 years. This never happened.

Here's the argument that should give a skeptic pause. Cannabis is one of the oldest medicines on earth. And for most of that history, it was used to stop vomiting, not cause it. A cannabis-driven vomiting syndrome appears nowhere in the record until 2004. Scroll it.

  1. c. 1550 BCE
    Ancient Egypt
    The Ebers Papyrus lists cannabis as medicine. Among the oldest written drug records on earth.[6]
  2. c. 1000 BCE
    Ayurveda, India
    Bhang is used as a digestive aid, to quicken digestion and calm the gut. A remedy for nausea, not a cause of it.[6]
  3. 8th-18th c.
    Medieval Islamic medicine
    Physicians document cannabis in detail and list it explicitly as an antiemetic, a drug that settles the stomach.[6]
  4. 1839
    O'Shaughnessy brings it West
    Cannabis enters Western medicine and, by the late 1800s, is in thousands of pharmacy preparations, many for nausea.
  5. 1894
    The largest study ever done
    The Indian Hemp Drugs Commission interviews about 1,200 witnesses and studies heavy daily users at a scale never repeated. It records plenty of harms. A cyclic-vomiting syndrome is not one of them.[7]
  6. 1970s
    Potency: about 1%
    The cannabis of the counterculture era averages roughly one to two percent THC, with meaningful CBD alongside it.[8]
For three thousand years, at low potency, nothing like CHS is described. Then the plant changes.
  1. 2004
    The first description
    Allen and colleagues in Adelaide, Australia, describe 19 chronic heavy users with cyclical vomiting relieved by hot bathing. CHS enters the medical literature.[1]
  2. 2012
    The 98-patient series
    A Mayo Clinic case series nails down the pattern, including hot-water relief in 91% of patients.[2]
  3. 2021
    A real trial
    The HaVOC randomized trial shows haloperidol beats standard Zofran for CHS.[19]
  4. 2024
    The guidelines arrive
    Gastroenterology and emergency-medicine bodies publish formal CHS management guidance.[3][4]
  5. Oct 1, 2025
    It gets a code
    ICD-10-CM R11.16. The condition is now official in US medicine.[5]
05It's rising

The emergency rooms are seeing it climb.

If this were just better awareness, you'd expect a gentle uptick. Instead, wherever cannabis became legal and commercial, ER visits for it rose sharply, and the rise tracks the arrival of high-potency product, not the legalization date itself.[11]

CHS emergency-room visits in Ontario, 2014 to 2021
Rate per 100,000 population. A roughly 13-fold rise over seven years.
0 1.0 2.0 3.0 Commercialization, 2020 2014 2021 0.26 3.43
Source: Myran et al., JAMA Network Open 2022, population-based interrupted time series.[11] The sharp jump followed commercial sales, not the 2018 legalization date, and was concentrated in ages 19 to 24.

Ontario is not alone. A Massachusetts analysis of more than 15 million ER visits found CHS cases up more than 1,350% from 2012 to 2021.[12] Colorado's cyclic-vomiting ER visits roughly doubled after cannabis liberalization.[13] Different states, same shape.

06The cost of not knowing

People suffer for years before anyone names it.

This is the part that makes the case personal. Because so few doctors recognize CHS, patients get bounced through the system for years, running up scans, scopes, and even surgeries that find nothing, while the real cause goes unnamed.[20]

17.9
emergency-room visits, on average, before a correct diagnosis.[20]
$76,920
average workup cost per patient before diagnosis, including unnecessary CT scans, endoscopies, and in the record, gallbladder removals that found nothing wrong.[20]
4.1 yrs
typical time from first ER visit to being told what it is.[4]
11.5%
of people whose symptoms fit CHS had ever received the diagnosis from a provider, in a 2026 national survey.[21]

That is the entire reason a page like this exists. The condition is common, brutal, and expensive, and it is still mostly invisible to the system meant to catch it.

07Why the hot shower

The strangest clue is also the most convincing.

Nearly every person with CHS discovers the same bizarre thing on their own, before they've read a word about it: a scalding hot shower stops the vomiting. It helps most people, 77% in the largest patient survey to date and up to 92% in the older clinical case series, and it's so specific that doctors now use it as a diagnostic tell.[26][2][16] A smaller group, about 17%, get the same relief from cold water instead.[26] When thousands of strangers independently land on the exact same strange fix, something real is going on.

What we honestly don't know yet

Why hot water works is still unsettled. The leading idea is that heat activates a receptor called TRPV1 that chronic cannabis dulls, which is also why capsaicin cream helps. But there are two other live theories, and the most thorough 2024 review says plainly that none has been proven.[17] Anyone who tells you the mechanism is settled is overselling. The relief is real and reliable. The explanation is still a working hypothesis.

08The pesticide question

"It's not the weed, it's what they spray on it."

This is the theory you'll hear most in the CHS community: it isn't the cannabis, it's pesticides, neem oil, or something added to the supply. It's an understandable place to look, and it deserves a real answer instead of a brush-off. Here's the honest one: as far as the evidence goes, that isn't what's happening, and three separate lines of it point the same way.

What the evidence actually shows

The researcher who ran the largest genetic study on CHS calls the pesticide theory "totally unsubstantiated."[27] A toxicologist on the survey team puts it plainly: identical cases show up from spotless licensed dispensaries and from illicit product alike, in every state, with no shared chemical signature, and that is simply not how poisoning works. Every pesticide has its own recognizable pattern of harm. CHS matches none of them.[26]

Where people got their cannabis before CHS started
Survey respondents could pick more than one source, so these don't add to 100.
A licensed, regulated dispensary61.9%
Illicit or gray market40%
Their own home grow19%
If contamination were the cause, cases would cluster at the dirty end of the market. Instead most came from clean, tested, licensed shelves. Source: Peterson et al., Cannabis & Cannabinoid Research 2026, n=1,134, peer reviewed. Still a self-selected survey, so treat the exact percentages as directional.[26]

And the single hardest fact for the pesticide theory to survive: in that survey, 28% of people said an episode was set off by the absence of cannabis, one to three days after they stopped.[26] Nothing sprayed on a plant can poison you once it's out of your system. That's a withdrawal pattern, not a poisoning one.

Where the concern is fair

None of this means cannabis is always clean. Pesticide contamination is a genuine problem in a loosely regulated market, and it's worth caring about. It just isn't the cause of this. Two true things at once: the supply should be tested better, and the syndrome is driven by heavy, high-potency THC, not by what's on it.

09The honest part

Where a careful skeptic is still right.

A page that only argued one side wouldn't deserve your trust. So here's what's genuinely unresolved, stated as plainly as the rest.

Correlation is not proof of cause

Potency rose and CHS appeared. That timing is striking, and it's the best explanation we have, but it is not proof. The rise is tangled up with more people using, using more often, legalization, and the plain fact that we diagnose it more now that it finally has a name. No study has cleanly separated a true increase from better detection. We think potency is the driver. We can't yet prove it.[11]

It can also be over-diagnosed

The same year the code arrived, doctors began warning that CHS is now sometimes slapped on too fast, before ruling out other causes. In one case a teenager's real problem, a compressed artery in the gut, was missed because everyone assumed CHS.[25] Both things are true at once: it's real and rising, and it should never be assumed. That's exactly why the guide side of this site keeps telling you to rule out other causes first. One clean way doctors separate it from its closest look-alike, cyclic vomiting syndrome: in that condition cannabis usually relieves an active episode, while in CHS it never does.

The evidence base is young

Some of what's repeated as fact rests on thin ground. The widely-quoted capsaicin recommendation traces to one underpowered 30-patient trial.[18] The genetic findings about who's susceptible come from a single small unreplicated study.[24] We've flagged those honestly rather than dressing them up. Twenty years in, this field is still early.

Do you have to quit forever?

A fair question, and the honest answer has two parts. A few clinicians who work closely with CHS report that some people, after a long break and a lot of self-awareness, can go back to a small amount of low-potency flower, never concentrates, and stay well by watching for their own early warning signs.[26] That path is real for a minority. It's also unproven, it needs a doctor who actually knows this syndrome, and in the same survey 70% of the people who went back had it return. So the message on this site doesn't change: total abstinence is the only cure anyone can count on. If you're standing in that shower tonight, that's the plan to trust.

One last thing, so we're clear.

This isn't about whether cannabis is good or bad, or a political argument in either direction. Most people who use cannabis will never get this. CHS is a specific syndrome that shows up in a subset of heavy, chronic, high-potency users. It's typically young adults, though clinicians have seen it from teenagers to people in their eighties, and it's often invisible until it isn't.

If any of this sounded like your 3 a.m., you already know which part was real. The good news is the same as the whole point: it ends when you stop.

So, now what?

If the evidence landed, the guide is where the practical help is, what to do tonight, what to say at the ER, and what quitting actually feels like.

Read the guide Get the ER card

Sources

  1. Allen JH et al. "Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse." Gut 2004. The first description. pubmed.ncbi.nlm.nih.gov/15479672
  2. Simonetto DA et al. "Cannabinoid Hyperemesis: A Case Series of 98 Patients." Mayo Clin Proc 2012. 91% hot-water relief. mayoclinicproceedings.org
  3. Rubio-Tapia A, McCallum R, Camilleri M. "AGA Clinical Practice Update on Diagnosis and Management of CHS." Gastroenterology 2024. gastro.org
  4. Borgundvaag B et al. "GRACE-4: cannabinoid hyperemesis syndrome management in the emergency department." Acad Emerg Med 2024. onlinelibrary.wiley.com/doi/10.1111/acem.14911
  5. ICD-10-CM R11.16, "Cannabis hyperemesis syndrome," effective Oct 1, 2025. icd10data.com · context: adai.uw.edu/icd-10-code-chs
  6. History of medical cannabis, including its long use as an antiemetic (Ayurveda, medieval Islamic medicine). en.wikipedia.org/wiki/History_of_medical_cannabis
  7. Indian Hemp Drugs Commission (1894), ~1,200 witnesses, heavy chronic users, no cyclic-vomiting syndrome recorded. en.wikipedia.org/wiki/Indian_Hemp_Drugs_Commission
  8. ElSohly MA et al. Potency Monitoring Program (DEA-seized samples): ~4% in 1995 to ~12% in 2014; THC:CBD ratio 14:1 to 80:1. Biol Psychiatry 2016. doi.org/10.1016/j.biopsych.2016.01.004
  9. Freeman TP et al. "Changes in delta-9-THC in cannabis over time: systematic review and meta-analysis." Addiction 2021. doi.org/10.1111/add.15253
  10. Cash MC et al. Legal-dispensary product testing, 9 states: average THC 19 to 22%. PLOS ONE 2020. doi.org/10.1371/journal.pone.0230167
  11. Myran DT et al. "Changes in ED Visits for CHS Following Legalization and Commercialization in Ontario." JAMA Netw Open 2022. 13-fold rise. doi.org/10.1001/jamanetworkopen.2022.31937
  12. Jangi S et al. "Increasing Prevalence of CHS in Young Adults and Minority Populations." Am J Gastroenterol 2025. >1,350% rise, Massachusetts. pubmed.ncbi.nlm.nih.gov/40511929
  13. Kim HS et al. Colorado ED cyclic-vomiting visits roughly doubled post-liberalization. Acad Emerg Med 2015. doi.org/10.1111/acem.12655
  14. Sinsemilla and cannabis potency history (selective breeding, not genetic modification). en.wikipedia.org/wiki/Sinsemilla
  15. Luo X et al. "Complete biosynthesis of cannabinoids in yeast." Nature 2019. Real transgenic science, not dispensary product. doi.org/10.1038/s41586-019-0978-9
  16. Sorensen CJ et al. "CHS: Diagnosis, Pathophysiology, and Treatment, a Systematic Review." J Med Toxicol 2017. 92.3% hot-water relief. link.springer.com
  17. Loganathan P, Gajendran M, Goyal H. "A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome." Pharmaceuticals 2024;17(11):1549. On hot bathing: "this proposed mechanism has not been empirically validated." doi.org/10.3390/ph17111549
  18. Dean DJ et al. "A Pilot Trial of Topical Capsaicin Cream for CHS." Acad Emerg Med 2020. The one RCT; 30 patients, underpowered. onlinelibrary.wiley.com/doi/10.1111/acem.14062
  19. Ruberto AJ et al. "IV Haloperidol Versus Ondansetron for Cannabis Hyperemesis (HaVOC)." Ann Emerg Med 2021. annemergmed.com
  20. Zimmer MB et al. "ED and Radiological Cost of Delayed Diagnosis of CHS." J Addict 2019. 17.9 visits, ~$77k, unnecessary surgeries. pmc.ncbi.nlm.nih.gov/articles/PMC6339733
  21. medRxiv 2026: US prevalence and correlates of CHS symptoms; 11.5% ever diagnosed. medrxiv.org
  22. Russo EB et al. "CHS Survey and Genomic Investigation." Cannabis Cannabinoid Res 2022. 79.4% relapse; candidate genes (single small study). liebertpub.com
  23. STAT News, "Is cannabinoid hyperemesis syndrome overdiagnosed?" July 2025. The overdiagnosis debate and the missed-artery case. statnews.com
  24. Peterson C, Simonian J, Mbengue M, Higgins J, Kirk R, Nava K, Lacinski R, Nelson A. "Cannabinoid Hyperemesis Syndrome, A Survey-Based Approach to Understanding Symptoms and Cannabis Use Patterns." Cannabis & Cannabinoid Research 2026;11(4):335-347. n=1,134. doi.org/10.1177/25785125261421434. Now peer reviewed and published; it was a conference presentation when this page was first written. Confirmed in the published paper: 61.9% sourced from a licensed dispensary, 96.5% used at least daily, 45% used six or more times a day, 65.4% used for over three years before symptoms began, 63.1% had symptoms clustered in the morning, and vape-cartridge use was associated with faster onset. The hot and cold bathing percentages, the withdrawal-triggered figure, and the relapse figures come from the same team's CannMed 2025 presentation of this dataset rather than the published abstract, and are still self-reported. Panel: youtube.com/watch?v=HXmN3-tMf9c
  25. Kwag KH, Basouny N, Brown B, Bialik I, Chhabra M. "Cardiovascular Complications of Cannabis: Reports of Prolonged QTc in Adolescents with Cannabinoid Hyperemesis Syndrome." J Fam Med Prim Care Open Acc 2022;6:202. Two adolescents with CHS, QTc 477 to 566 ms alongside low potassium (2.7 and 3.3 mmol/L); the longer QTc normalised after potassium was replaced. Both received haloperidol. The authors note haloperidol can prolong QT by 15 to 30 ms and suggest antiemetics without that effect in these patients.
  26. Johns Hopkins All Children's Hospital, Cannabinoid Hyperemesis Syndrome Clinical Pathway, updated Aug 2025. Requires a metabolic panel to check electrolytes and kidney function, advises ECG and cardiac monitoring before IV haloperidol, and states opioids are not advised. hopkinsmedicine.org clinical pathway (PDF)
  27. Gabbert CT, Bhuiyan F, Truitt TJ. "Chasing Highs, Experiencing Lows: A Case of Hypokalemia Associated With Cannabis Use." Cureus 2025;17(4):e83194. Daily cannabis user with potassium of 1.8 mmol/L and a QTc of 628 ms. pmc.ncbi.nlm.nih.gov/articles/PMC12121849
  28. Russo EB. Review of CHS causation theories (pesticides, viruses, genetic predisposition), Frontiers in Toxicology, Oct 2024; and Russo EB et al., genomic investigation, Cannabis Cannabinoid Res 2022. Calls the pesticide-causation theory unsubstantiated. frontiersin.org/journals/toxicology